Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical phenylquinoline and chromen-2-one triazole compounds

Pharmaceutical phenylquinoline and chromen-2-one triazole compounds

US Patent 7960409 · Granted Jun 14, 2011

Estimated economic value: $55,704,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic mitochondrial activity inhibitors and uses thereof2025
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2024
Heterocyclic mitochondrial activity inhibitors and uses thereof2023
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2020
Compounds and use thereof in the expansion of hematopoietic stem cells and/or he2020
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2019
Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoie2019
Benzothiazole and benzothiophene compounds2019
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2018
Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo2018
Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitor2018
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2017